ambrisentan
UkraineDrugs containing this active substance
-
The drug is intended for the treatment of pulmonary arterial hypertension in adult patients (including idiopathic hypertension or connective tissue diseases).
Form: tablets, film-coated
Active substance Dosage ambrisentan 5 mg ATC: C02KX02
Manufacturer: APL Swift Services (Malta) Limited (Responsible for batch release)
-
The drug is intended for the treatment of pulmonary arterial hypertension in adult patients (WHO functional class II–III), specifically as part of combination therapy.
Form: tablets, film-coated
Active substance Dosage ambrisentan 10 mg ATC: C02KX02
Manufacturer: APL Swift Services (Malta) Limited (Responsible for batch release)